Skip to content
  • Pharma SOP’s
  • Schedule M
  • Pharma tips
  • Pharma Stability Studies

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Tag: Risk management in GMP

How PMDA GMP Affects the Pharmaceutical Supply Chain in Japan

Posted on December 13, 2024 By digi

How PMDA GMP Affects the Pharmaceutical Supply Chain in Japan How PMDA GMP Affects the Pharmaceutical Supply Chain in Japan Introduction to PMDA GMP and Its Impact on the Pharmaceutical Supply Chain The Pharmaceutical and Medical Devices Agency (PMDA) enforces Good Manufacturing Practices (GMP) guidelines in Japan, ensuring that pharmaceutical products are consistently produced and…

Read More “How PMDA GMP Affects the Pharmaceutical Supply Chain in Japan” »

PMDA GMP Guidelines

How to Train Your Team to Meet EMA GMP Standards

Posted on December 13, 2024 By digi

How to Train Your Team to Meet EMA GMP Standards Effective Strategies for Training Your Team to Meet EMA GMP Standards Introduction to EMA GMP Standards Training The European Medicines Agency (EMA)’s Good Manufacturing Practices (GMP)) are critical for ensuring the safety, quality, and efficacy of pharmaceutical products. For pharmaceutical companies, achieving and maintaining compliance…

Read More “How to Train Your Team to Meet EMA GMP Standards” »

EMA GMP Guidelines

The Importance of Documentation in NMPA GMP Compliance

Posted on December 13, 2024 By digi

The Importance of Documentation in NMPA GMP Compliance The Importance of Documentation in NMPA GMP Compliance Introduction to NMPA GMP Documentation Requirements The National Medical Products Administration (NMPA), formerly the China Food and Drug Administration (CFDA), plays a critical role in ensuring the safety, efficacy, and quality of pharmaceutical products in China. One of the…

Read More “The Importance of Documentation in NMPA GMP Compliance” »

NMPA GMP Guidelines

COFEPRIS GMP Standards and the Manufacture of Biologics in Mexico

Posted on December 13, 2024 By digi

COFEPRIS GMP Standards and the Manufacture of Biologics in Mexico COFEPRIS GMP Standards and the Manufacture of Biologics in Mexico Introduction to COFEPRIS and GMP Regulations in Mexico In Mexico, the pharmaceutical industry is regulated by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS), which ensures that all pharmaceutical products meet the highest…

Read More “COFEPRIS GMP Standards and the Manufacture of Biologics in Mexico” »

GMP in Latin America (ANVISA, COFEPRIS)

Key Changes in Schedule M (Revised) GMP: What You Need to Know

Posted on December 13, 2024 By digi

Key Changes in Schedule M (Revised) GMP: What You Need to Know Understanding the Key Changes in Schedule M (Revised) GMP Guidelines Introduction to Schedule M (Revised) India’s pharmaceutical sector is one of the largest globally, and its reputation depends heavily on adherence to stringent regulatory standards. The Schedule M (Revised) guidelines under the Drugs…

Read More “Key Changes in Schedule M (Revised) GMP: What You Need to Know” »

SCHEDULE - M - Revised

TGA GMP Compliance for Small and Medium Pharma Companies in Australia

Posted on December 13, 2024 By digi

TGA GMP Compliance for Small and Medium Pharma Companies in Australia Achieving TGA GMP Compliance for Small and Medium Pharmaceutical Companies in Australia Introduction to TGA GMP Compliance The Therapeutic Goods Administration (TGA) enforces Good Manufacturing Practice (GMP) standards to ensure the quality, safety, and efficacy of pharmaceutical products in Australia. For small and medium-sized…

Read More “TGA GMP Compliance for Small and Medium Pharma Companies in Australia” »

TGA GMP Guidelines

MHRA GMP Compliance for Small and Medium Pharmaceutical Companies

Posted on December 13, 2024 By digi

MHRA GMP Compliance for Small and Medium Pharmaceutical Companies Achieving MHRA GMP Compliance for Small and Medium Pharmaceutical Companies Introduction to MHRA GMP Compliance For small and medium-sized pharmaceutical companies (SMEs), achieving and maintaining compliance with the Medicines and Healthcare products Regulatory Agency (MHRA) Good Manufacturing Practices (GMP) can be a daunting task. MHRA GMP…

Read More “MHRA GMP Compliance for Small and Medium Pharmaceutical Companies” »

MHRA GMP Guidelines

How to Achieve WHO GMP Certification in Pharmaceutical Manufacturing

Posted on December 12, 2024 By digi

How to Achieve WHO GMP Certification in Pharmaceutical Manufacturing A Step-by-Step Guide to Achieving WHO GMP Certification in Pharmaceutical Manufacturing Introduction to WHO GMP Certification The World Health Organization (WHO)’s Good Manufacturing Practices (GMP)) certification is a globally recognized standard that demonstrates a pharmaceutical manufacturer’s commitment to producing high-quality, safe, and effective medicines. Achieving WHO…

Read More “How to Achieve WHO GMP Certification in Pharmaceutical Manufacturing” »

WHO GMP Guidelines

PMDA GMP Guidelines for Biologics: Key Compliance Requirements

Posted on December 12, 2024 By digi

PMDA GMP Guidelines for Biologics: Key Compliance Requirements PMDA GMP Guidelines for Biologics: Key Compliance Requirements Introduction to PMDA GMP Guidelines for Biologics Biologics, including vaccines, monoclonal antibodies, gene therapies, and recombinant proteins, are complex pharmaceutical products derived from living organisms. Due to the intricate nature of biologic manufacturing, ensuring the safety, efficacy, and quality…

Read More “PMDA GMP Guidelines for Biologics: Key Compliance Requirements” »

PMDA GMP Guidelines

The Impact of EMA GMP Standards on the Pharmaceutical Supply Chain

Posted on December 12, 2024 By digi

The Impact of EMA GMP Standards on the Pharmaceutical Supply Chain How EMA GMP Standards Shape the Pharmaceutical Supply Chain Introduction to EMA GMP Standards and the Supply Chain The pharmaceutical supply chain is a complex network of processes involving the sourcing, production, storage, and distribution of medicinal products. The European Medicines Agency (EMA)’s Good…

Read More “The Impact of EMA GMP Standards on the Pharmaceutical Supply Chain” »

EMA GMP Guidelines

Posts pagination

Previous 1 … 90 91 92 … 99 Next

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • GMP Blog

Risk management in GMP

  • How Schedule M Revised Impacts Pharmaceutical Research and Development (R&D) in India
  • How to Streamline Your GMP Processes to Meet EMA and MHRA Requirements
  • Future Trends in Schedule M Revised Compliance and Its Impact on the Indian Pharmaceutical Industry
  • How to Build a Culture of GMP Compliance in Pharmaceutical Manufacturing in Europe
  • How Schedule M Revised Contributes to the Overall Quality Assurance of Indian Pharmaceutical Products
  • How to Ensure GMP Compliance for Pharmaceutical Drug Products in Europe
  • The Role of Regulatory Bodies in Enforcing GMP for Pharmaceutical Manufacturing in Europe
  • The Role of Data Integrity in Compliance with Schedule M Revised for Indian Pharmaceutical Manufacturers
  • How MHRA Ensures GMP Compliance in the UK Pharmaceutical Manufacturing Sector
  • Best Practices for GMP Compliance in High-Risk Drug Manufacturing in Emerging Markets

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme